About Sublimed
Sublimed is a company based in Moirans (France) founded in 2015 by Simon Perraud. Sublimed has raised $3.44 million across 1 funding round from investors including Kreaxi, C2AD and CEA Investissement. Sublimed offers products and services including actiTENS. Sublimed operates in a competitive market with competitors including NeuroMetrix, Remedee Labs, Sky Medical Technology, Electromedical Technologies and Galvani Bioelectronics, among others.
- Headquarter Moirans, France
- Founders Simon Perraud
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Sublimed
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$3.44 M (USD)
in 1 rounds
-
Latest Funding Round
$3.44 M (USD), Series A
Jan 13, 2019
-
Investors
Kreaxi
& 3 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Sublimed
Sublimed offers a comprehensive portfolio of products and services, including actiTENS.
Connected device for electrical pain relief without medications.
Funding Insights of Sublimed
Sublimed has successfully raised a total of $3.44M through 1 strategic funding round. The most recent funding activity was a Series A round of $3.44 million completed in January 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Sublimed
Sublimed has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include Kreaxi, C2AD and CEA Investissement.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Kreaxi is engaged in equity financing for innovative startups.
|
Locked | Locked | Locked | |
|
Investment services are provided by C2AD for businesses in France.
|
Locked | Locked | Locked | |
|
Investments in startups are facilitated to valorize CEA technologies.
|
Locked | Locked | Locked |
Investor details for Sublimed
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Sublimed
Investment portfolio details for Sublimed
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Sublimed
Detailed financials for Sublimed
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Sublimed Comparisons
Peer comparison for Sublimed
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Sublimed
Sublimed operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as NeuroMetrix, Remedee Labs, Sky Medical Technology, Electromedical Technologies and Galvani Bioelectronics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Wearable technology for pain, nerve disease and sleep disorders
|
|
| Locked | Locked | Locked |
Endorphin stimulation therapy for pain management is developed.
|
|
| Locked | Locked | Locked |
Electro-stimulation devices are manufactured for deep vein thrombosis treatment.
|
|
| Locked | Locked | Locked |
An electrotherapy device that helps reduce and eliminate chronic or acute pain
|
|
| Locked | Locked | Locked |
Implantable neuromodulation devices for chronic disease treatment are developed.
|
|
| Locked | Locked | Locked |
A wearable neuromodulation device for pain relief is developed.
|
Detailed competitors of Sublimed
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Sublimed
Complete news archive for Sublimed
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sublimed
Sublimed was founded in 2015 and raised its 1st funding round 4 years after it was founded.
Sublimed is headquartered in Moirans, France. It is registered at Moirans, Auvergne-rhone-alpes, France.
Sublimed is a funded company, having raised a total of $3.44M across 1 funding round to date.
Sublimed is developing medical devices for the treatment of chronic pain. The devices utilizes the principle of transcutaneous electrical neurostimulation for the treatment. The device is invisible under clothing and can stimulate all areas of the body. It relieves pain using electrical impulses for muscle or nerve fibers via electrodes placed in contact with the skin. The device is CE approved.
Sublimed's top competitors include Remedee Labs, Sky Medical Technology and Electromedical Technologies.
Sublimed offers actiTENS.
Sublimed has 4 investors. Key investors include Kreaxi, C2AD, CEA Investissement, and Investisseur Prive.